ARCHIVES

Pfizer’s Withdrawal Of Mylotarg Signals Stronger FDA Resolve To Monitor Confirmatory Studies

This article is from The Cancer Letter archive.

Vol. 36 No. 24 | June 25, 2010

Download PDF Visit The Full Archive

Related Articles

In Brief: Pitot Appointed To Cancer Panel, Replacing Jako; Fisher, Wattenberg, Curtiss Lead Cancer Groups

May 29, 1992

Oral UFT Equivalent To FULV In Stage II and III Colon Cancer

July 30, 2004

Nurses Pass Resolution To Support Research on Ethnic Patient Issues

May 29, 1992

Women’s Health Initiative Trial Produced $37.1 Billion in Returns

May 9, 2014

Greenwald Disagrees With WHT Report But Won’t Fight Decision; Will Ask For Limited Study, With Scope To Be Modified

January 15, 1988

NCAB Member Becker Says AACR ‘Feels Disenfranchised’

December 6, 1991